Who to call at INmune Bio Inc., and when
Fundz watches for the moments INmune Bio Inc. starts buying, and tells you who to reach.
- An alert the day INmune Bio Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at INmune Bio Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at INmune Bio Inc.. With Fundz connected, it knows.
INmune Bio Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
inmunebio.comAI Executive Summary
AI-powered analysis of 8-K filing content
INmune Bio entered into employment agreements on November 26, 2025 with CEO David J. Moss and CFO Cory Ellspermann, setting base salaries, target bonuses, stock option grants, and change-of-control vesting and severance terms. The agreements are compensation and retention arrangements for existing leadership rather than leadership changes.
Key Takeaways
David J. Moss (President and CEO) receives a $500,000 base salary effective November 1, 2025, a discretionary bonus target of 50% of base salary, and an option to purchase 800,000 shares.
Cory Ellspermann (CFO) receives a $275,000 base salary effective November 1, 2025, a discretionary bonus target of 40% of base salary, and an option to purchase 300,000 shares.
3 more takeaways
Related Filings (25)
25 more filings from INmune Bio Inc. in the last 90 days
Filing Overview
What This Means
INmune Bio Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.